Company Overview and News

34
New Lows Almost Certainly Are in the Future for Petrobras Stock

16h investorplace
Petrobras – Petroleo Brasileiro S.A. (PBR) (NYSE:PBR) has been so volatile it might make investors sick. Some might be asking whether they’re riding a roller coaster or are long on PBR stock.
UPS XOM PXD FDX GOOG PBR EOG COP X GOOGL CVX OIH

52
Short Sellers Run For Cover From Major Oil Stocks

2018-06-12 247wallst
Crude oil has been trading near $66 a barrel early on Tuesday. This is the lowest that crude oil has been at since mid-April. This comes after oil reached above $70 in late May for the first time in years. If anything, this drop might offer some stabilization, but how quickly oil will recover and then some is yet to be seen. The current crude price still pales in comparison to what it was in 2014.
COP BP XOM CVX BP BPAQF OXY PBR BP.A BP.B

2
What Happens When The Dollar Double Whammy Lands On You (Again)

2018-06-06 seekingalpha
A recent poll in Brazil showed that one-third of Brazilians favor "military intervention." The country had been gripped by a crippling truckers strike, the results of which have been almost complete economic shutdown. Intervention, as it is softly termed, would be nothing less than a coup.
PBR

2
Emerging Markets - What Now?

2018-06-02 seekingalpha
The Emerging Markets ended a 10-year bear market in Q1 '16, as the EEM (iShares MSCI Emerging Markets ETF) peaked in the $55 area in October 2007, the VWO (Vanguard FTSE Emerging Markets ETF) peaked near $58 in November 2007, where both bottomed in Q1 '16 near $30 per share.
PBR VWO EEM

3
PBR: Petroleo Brasileiro SA Petrobras - Stock Quote and News - CNBC

2018-06-01 cnbc
Like all ChartIQ markers, the object itself is managed by the chart, so when you scroll the chart the object moves with you. It is also destroyed automatically for you when the symbol is changed.
PBR.A PBR PBRQF

3
Brazil: Strike Weakens, But Fiscal Worries Deepen

2018-05-31 think.ing
Brazil’s chief challenge is its unsustainable fiscal trajectory, which can only be addressed with the election of a new administration committed to fiscal austerity, and with considerable political capital to approve much-needed but unpopular initiatives.
PBR

185
Friday’s Vital Data: Micron Technology, Inc. (MU), Bank of America Corp (BAC) and Petróleo Brasileiro S.A. Petrobras (PBR)

2018-05-27 investorplace
U.S. stock futures are trading higher this morning, which is a bit surprising. President Donald Trump cancelled the U.S.’s summit with North Korea yesterday. What’s surprising is that North Korea kept its cool and did not ratchet up rhetoric in response.
BAC MU PBR

156
20 Oil Stocks for an Unpredictable Second Half

2018-05-25 investorplace
Despite their enticing nature, oil stocks are always tricky. Subject to multiple factors, particularly geopolitical pressures, the energy sector is often a hit-or-miss affair. Additionally, with the current Trump administration at the helm over unprecedented issues, this year should be especially unpredictable.
APC APA XOM HES LONE PXD DVN CXO RDSB TOT RDSA COP HES.PRA RYDAF FP RDS.B NBL RDS.A SNP CTLR PBR EOG BP CVX RYDBF MRO CLR WRD AEUA

2
BRF SA Looking At A Long Road Back

2018-05-11 seekingalpha
Amidst ongoing regulatory/legal and operational challenges, shareholders have elected a new board of directors, that includes the highly-respected CEO of Petrobras.
PBR

53
Major Oil Boom Shocks Short Sellers

2018-05-10 247wallst
Crude oil is finally back above $70 a barrel after suffering for a while. Before this, oil had not been at this price level in over two years. Crude only reached above $70 this past week but the question remains whether it will stay. Recent Middle East tensions have helped push the price higher as well. The current crude price still pales in comparison to what it was in 2014.
XOM BP PBR BP.A BP.B COP BP CVX BPAQF OXY APR APRLY

2
Petrobras (PBR) Q1 2018 Results - Earnings Call Transcript

2018-05-09 seekingalpha
Petrobras - Petroleo Brasileiro S.A. (NYSE:PBR) Q1 2018 Earnings Conference Call May 8, 2018 1:00 PM ET
PBR

2
Pre-Salt Reserves Make Brazil Ripe For Investment, But Risk Remains

2018-05-02 seekingalpha
On October 27, 2017, new auction rounds for the eight pre-salt blocks in Brazil were launched. As the Brazilian government approved a new regulatory framework for the bidding process to allow more investors, 14 foreign companies and two Brazilian entities were qualified to participate in the auction.
PBR STO

53
Ensco Q1 Conference Call Takeaways

2018-04-29 seekingalpha
Shallow-water market is seeing increased demand due to strength in the North Sea and the Middle East.
DO RDC BP NE ESV PGNPQ CVX TOT RIG PBR

52
Short Sellers Pile Into Major Oil Stocks

2018-04-25 247wallst
Crude oil is back above $67 a barrel after suffering through a rough March, and before this oil had not been at this price level in over two years. We saw crude actually come within a dollar of the $70 price level. Recent Middle East tensions have helped push the price higher. The current crude price still pales in comparison to what it was in 2014.
XOM BP PBR BP.A BP.B COP BP CVX BPAQF OXY APR APRLY

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

3h - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

Silicon Investor Message Boards

This table lists all message boards related to PBR / Petroleo Brasileiro SA Petrobras ADR on message board site Silicon Investor.

PBR - Petrobras PBRR; Pawnbroker.com
CUSIP: 71654V408